Carbapenem-resistant K. pneumoniae (CRKP) is the most common CRE, and its prevalence of CRKP increased from 2.9% to 24.2% between 2005 and 2022. The spread of CRKP and its clinical outcomes pose a con
Carbapenem-resistant K. pneumoniae (CRKP) is the most common CRE, and its prevalence of CRKP increased from 2.9% to 24.2% between 2005 and 2022. The spread of CRKP and its clinical outcomes pose a con
